Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
![]() |
|||||
GSE261834 |
Distinct structural and functional heterochromatin partitioning of lamin B1 and lamin B2 revealed using genome-wide Nicking Enzyme Epitope targeted DNA sequencing.
|
|
51 |
|
Sriharsa Pradhan | Jan 16, 2025 | ||
GSE287248 |
Angiotensin receptor blockers and CD4 T cell transcriptional and epigenetic states in systemic lupus erythematosus. RNAseq [ATAC-seq]
|
|
102 | Terri Laufer | Jan 17, 2025 | |||
GSE194318 |
Cleavage Under Targets and Tagmentation(CUT&Tag)analysis of ovarian cancer cells treated by Paeonol
|
|
3 | Jingchun Liu | Jan 18, 2025 | |||
GSE252096 |
The distribution of HP1α in the genome of intrahepatic cholangiocarcinoma cells
|
|
2 |
|
Fei Xiong | Jan 20, 2025 | ||
GSE252098 |
The profiling of methylation and acetylation modification of histone H3 in Intrahepatic cholangiocarcinoma cells
|
|
6 |
|
Fei Xiong | Jan 20, 2025 | ||
GSE263326 |
Cardiac differentiation roadmap for analysis of plasticity and balanced lineage commitment
|
|
4 | Rebecca Regina Snabel | Jan 27, 2025 | |||
GSE274958 |
Effects of MRSA and FTY720 S-phosphonate on H3K9 acetylation in human lung endothelial cells
|
|
5 |
|
Mark Maienschein-Cline | Jan 28, 2025 | ||
GSE282996 |
ATOH8 confers the vulnerability of tumor cells to ferroptosis by repressing SCD expression [ChIP-Seq]
|
|
4 | Huixiang Xiao | Jan 30, 2025 | |||
GSE241864 |
The SLC1A1/EAAT3 Dicarboxylic Amino Acid Transporter is an Epigenetically Dysregulated Nutrient Carrier that Sustains Oncogenic Metabolic Programs
|
|
8 | Abhishek Chakraborty | Jan 31, 2025 | |||
GSE270591 |
Targeting redox-sensitive MBD2-NuRD condensate for tumor therapy
|
|
34 |
|
heyang wei | Feb 01, 2025 | ||
GSE285330 |
KLF7 regluate migration and cancer stemness in OSCC [ChIP-seq]
|
|
2 | Jiong Lyu | Feb 01, 2025 | |||
GSE285799 |
MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia [ATAC-seq]
|
|
8 |
|
Ruud Delwel | Feb 01, 2025 | ||
GSE285800 |
MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia [ChIP-seq]
|
|
28 | Ruud Delwel | Feb 01, 2025 | |||
GSE286033 |
MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia
|
|
105 | Ruud Delwel | Feb 01, 2025 | |||
GSE288169 |
Intrapulmonary metastases of non-small cell lung cancer promoted by a hotspot gain-of-function mutation in KMT2C
|
|
|
31 | Yiman Peng | Feb 01, 2025 | ||
GSE236062 |
Comprehensive Interrogation of Synthetic Lethality in the DNA Damage Response
|
|
25 |
|
Markus S Schröder | Feb 03, 2025 | ||
GSE197519 |
Vanguard is a glucose deprivation-responsive long non-coding RNA essential for chromatin remodeling-reliant DNA repair
|
|
2 |
|
Ben Zhang | Feb 09, 2025 | ||
GSE235181 |
Promoter-proximal RNA polymerase II termination regulates transcription during human cell type transition
|
|
44 |
|
Michael Lidschreiber | Feb 10, 2025 | ||
GSE261369 |
SMARCA4 Inhibits Breast Tumor progression through Transcriptional Activation of GTPase Activating Factor ARHGAP29 and RHOA Suppression [ATAC]
|
|
4 | Yong Wei | Feb 12, 2025 | |||
GSE268677 |
LINE1 elements at Distal Junctions of rDNA repeats regulate nucleolar organization in human embryonic stem cells [ATAC-seq]
|
|
8 |
|
Lamisa Ataei | Feb 12, 2025 |